Editorial comment

J Urol. 2010 Aug;184(2):500. doi: 10.1016/j.juro.2010.03.168. Epub 2010 Jun 17.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
  • Male
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / diagnosis
  • Prostatic Neoplasms / epidemiology*
  • Risk Factors

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Prostate-Specific Antigen